31-Gene Expression Profile Testing Survival Benefit in a Population-based Analysis of Cutaneous Melanoma Patients ≥65 Years of Age. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 6, n. 2, p. s24, 2022. DOI: 10.25251/skin.6.supp.24. Disponível em: https://skin.dermsquared.com/skin/article/view/1541. Acesso em: 18 may. 2025.